| 101 |
|
Progestins and breast cancer/
|
Eden, J
|
C.V. Mosby Co
|
1900
|
|
|
|
| 102 |
|
Prognostic evaluation of patients with clinical T1 and T2 squamous cell carcinomas of the thoracic esophagus after 3-field lymph node dissection/
|
Igaki, H
|
C. V. Mosby Co
|
2003
|
|
|
|
| 103 |
|
Prognostic factors associated with antenatal subchorionic echolucencies/
|
Sharma, G
|
C.V. Mosby Co
|
1900
|
|
|
|
| 104 |
|
Prognostic factors for poor survival after repeat hepatectomy in patients with colorectal liver metastases/
|
Takahashi, S
|
C. V. Mosby Co
|
2003
|
|
|
|
| 105 |
|
Prognostic implication of creatine kinase release after elective percutaneous coronary intervention in the pre-IIb/IIIa antagonist era/
|
Ghazzal, Z
|
C. V. Mosby Co
|
2003
|
|
|
|
| 106 |
|
Prognostic implications of ejection fraction from linear echocardiographic dimensions: the strong heart study/
|
Devereux, R. B
|
C. V. Mosby Co
|
2003
|
|
|
|
| 107 |
|
Prognostic importance of the oxidized product of catecholamines, adrenolutin, in patients with severe heart failure/
|
Rouleau, J. L
|
C. V. Mosby Co
|
2003
|
|
|
|
| 108 |
|
Prognostic significance of coronary artery calcium in asymptomatic subjects with usual cardiovascular risk/
|
Alexopoulos, D
|
C. V. Mosby Co
|
2003
|
|
|
|
| 109 |
|
Prognostic significance of morphometric endomyocardial biopsy analysis in patients with idiopathic dilated cardiomyopathy/
|
Grimm, W
|
C. V. Mosby Co
|
2003
|
|
|
|
| 110 |
|
Prognostic significance of RET and NTRK1 rearrangements in sporadic papillary thyroid carcinoma/
|
Musholt, Thomas J
|
C. V. Mosby Co
|
2001
|
|
|
|
| 111 |
|
Prognostic value of hMLH1 methylation and microsatellite instability in pancreatic endocrine neoplasms/
|
House, M. G
|
C. V. Mosby Co
|
2003
|
|
|
|
| 112 |
|
Progress in Cardiology - Combination of minimally invasive coronary bypass and percutaneous transluminal coronary angioplasty in the treatment of double-vessel coronary disease: Two-year follow-up of a new hybrid procedure compared with "on-pump" double bypass grafting/
|
Canni�re, D de
|
C. V. Mosby Co
|
2001
|
|
|
|
| 113 |
|
Progress in Cardiology - Different expressivity of a ventricular essential myosin light chain gene Ala57Gly mutation in familial hypertrophic cardiomyopathy/
|
Lee, Won-Ha
|
C. V. Mosby Co
|
2001
|
|
|
|
| 114 |
|
Progress in Cardiology - Evaluation of early postoperative results after bicaval versus standard cardiac transplantation and review of the literature/
|
Milano, Carmelo A
|
C. V. Mosby Co
|
2000
|
|
|
|
| 115 |
|
Progress in Cardiology - Infarct artery reocclusion after primary angioplasty, stent placement, and thrombolytic therapy for acute myocardial infarction/
|
Wilson, Stephanie H
|
C. V. Mosby Co
|
2001
|
|
|
|
| 116 |
|
Progress in Cardiology - INTER-HEART: A global study of risk factors for acute myocardial infarction/
|
Ounpuu, Stephanie
|
C. V. Mosby Co
|
2001
|
|
|
|
| 117 |
|
Progress in Cardiology - Multimodality reperfusion therapy for acute myocardial infarction/
|
Cannon, Christopher P
|
C. V. Mosby Co
|
2000
|
|
|
|
| 118 |
|
Progress in Cardiology - Noninvasive tests of vascular function and structure: Why and how to perform them/
|
Fathi, Robert
|
C. V. Mosby Co
|
2001
|
|
|
|
| 119 |
|
Progress in Cardiology - Prognostic implications of left ventricular hypertrophy
|
Vakili, Babak A
|
C. V. Mosby Co
|
2001
|
|
|
|
| 120 |
|
Progress in Cardiology - Rationale for the use of combination angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker therapy in heart failure/
|
Carson, Peter E
|
C. V. Mosby Co
|
2000
|
|
|
|